News reports

National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.

Non-Hodgkin lymphoma treatment gets the green light for NHS use in England 

The National Institute for Health and Care Excellence has recommended a new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma.

One third of cancer patients say coronavirus has impacted their treatment

One in three cancer patients said their treatment was impacted by the effects of COVID-19 on the health system, according to survey results.

Targeted treatment for leukaemia approved on NHS in England 

The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.  

New treatment for rare blood cancer approved for NHS use in England

The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England.

Urgent cancer referrals being turned down during coronavirus pandemic 

Around a quarter of GPs have said that urgent referrals for suspected cancer had been turned down by hospitals more often than before the pandemic.

Pages